For more than a century, heparin has been the go-to anticoagulant to prevent harmful blood clots in blood vessels or the ...
The global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and life-threatening conditions such as ...